Article Details

Japan's Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market

Retrieved on: 2024-11-04 06:18:35

Tags for this article:

Click the tags to see associated articles and topics

Japan's Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market. View article details on hiswai:

Excerpt

Japan's Shimadzu Corp partners with US-based Sepragen marking entry into biopharma market. 04 November 2024 | News. Share. Shimadzu will exclusively ...

Article found on: www.biospectrumasia.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo